Arun Agrawal In the US, the National Institute of Health's attempt to patent partial cDNA sequences corresponding to gene fragments in human brain tissue has sparked off a controversy which impinges on ethical issues and is critical to the evolution of the patent law on human interventions in naturally occurring substances.
